Bank of America’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89M | Buy |
513,801
+243,825
| +90% | +$2.32M | ﹤0.01% | 3336 |
|
|
2025
Q1 | $2.82M | Buy |
269,976
+147,335
| +120% | +$1.54M | ﹤0.01% | 3666 |
|
|
2024
Q4 | $2.89M | Sell |
122,641
-169,071
| -58% | -$3.98M | ﹤0.01% | 3480 |
|
|
2024
Q3 | $10.5M | Buy |
291,712
+114,938
| +65% | +$4.13M | ﹤0.01% | 2597 |
|
|
2024
Q2 | $6.24M | Buy |
176,774
+24,142
| +16% | +$852K | ﹤0.01% | 2935 |
|
|
2024
Q1 | $4.33M | Buy |
152,632
+111,850
| +274% | +$3.18M | ﹤0.01% | 3161 |
|
|
2023
Q4 | $542K | Sell |
40,782
-52,979
| -57% | -$705K | ﹤0.01% | 4564 |
|
|
2023
Q3 | $840K | Buy |
93,761
+2,029
| +2% | +$18.2K | ﹤0.01% | 4145 |
|
|
2023
Q2 | $1.03M | Buy |
91,732
+19,761
| +27% | +$222K | ﹤0.01% | 4006 |
|
|
2023
Q1 | $829K | Buy |
71,971
+36,205
| +101% | +$417K | ﹤0.01% | 4298 |
|
|
2022
Q4 | $415K | Sell |
35,766
-15,053
| -30% | -$174K | ﹤0.01% | 4807 |
|
|
2022
Q3 | $645K | Buy |
50,819
+22,510
| +80% | +$286K | ﹤0.01% | 4487 |
|
|
2022
Q2 | $195K | Sell |
28,309
-4,463
| -14% | -$30.7K | ﹤0.01% | 5359 |
|
|
2022
Q1 | $316K | Sell |
32,772
-31,247
| -49% | -$301K | ﹤0.01% | 5414 |
|
|
2021
Q4 | $762K | Buy |
64,019
+50,716
| +381% | +$604K | ﹤0.01% | 4785 |
|
|
2021
Q3 | $216K | Sell |
13,303
-335
| -2% | -$5.44K | ﹤0.01% | 5416 |
|
|
2021
Q2 | $287K | Buy |
13,638
+433
| +3% | +$9.11K | ﹤0.01% | 5085 |
|
|
2021
Q1 | $205K | Buy |
13,205
+566
| +4% | +$8.79K | ﹤0.01% | 5368 |
|
|
2020
Q4 | $265K | Buy |
+12,639
| New | +$265K | ﹤0.01% | 4709 |
|